M-M-RVAXPRO subst sèche c solv ser pré 10 pce
7680007030021
CH-703
J07BD52
08.08.
1 / 3
google
Details
- Product number
- 0070301
- CPT
- -
- Packaging group
- 10
- Unit
- Durchstechflasche(n)
- Composition
- Vaccinum attenuatum: virus morbilli vivus (Stamm Edmonston-Enders) min. 1000 U., virus parotitis vivus (Stamm Jeryl Lynn) min. 12500 U., virus rubella vivus (Stamm Wistar RA 27/3) min. 1000 U., gelatina hydrolysata, medium 199, minimal essential medium (MEM), natrii hydrogenoglutamas monohydricus, neomycinum, phenolsulfonphthaleinum, dikalii phosphas anhydricus, kalii dihydrogenophosphas, natrii hydrogenocarbonas, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, sorbitolum 14.5 mg, saccharum, albuminum humanum, natrii hydroxidum, acidum hydrochloridum, pro vitro corresp. natrium 2.45 mg et kalium 0.09 mg. Solvens: aqua ad iniectabile.
Articles (1)
M-M-RVAXPRO, Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension
Pulver
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
SOLV
|
- | Substance | HNIDK |
|
VACA
|
- | Substance | Wirkstoff (Principe actif) |
|
VACA
|
- | Substance | Wirkstoff (Principe actif) |
|
VACA
|
- | Substance | Wirkstoff (Principe actif) |
|
VACA
|
- | Substance | HNIDK |
|
VACA
|
- | Substance | HNIDK |
|
VACA
|
- | Substance | HNIDK |
|
VACA
|
- | Substance | AIMDK |
|
VACA
|
- | Substance | RESI |
|
VACA
|
- | Substance | FNIDK |
|
VACA
|
- | Substance | HNIDK |
|
VACA
|
- | Substance | HNIDK |
|
VACA
|
- | Substance | HNIDK |
|
VACA
|
- | Substance | HNIDK |
|
VACA
|
- | Substance | HNIDK |
|
VACA
|
14.5 MG | Substance | HBESI |
|
VACA
|
- | Substance | HNIDK |
|
VACA
|
- | Substance | RESI |
|
VACA
|
- | Substance | HNIDK |
|
VACA
|
- | Substance | HNIDK |
|
VACA
|
2.45 MG | Substance | HBESI |
|
VACA
|
0.09 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 219.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/07/2020
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 703
- Drug name
- M-M-RVAXPRO, Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension
- Galenic form
- PULMSS
- ATC Code
- J07BD52
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 13/02/2007
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- M M RVAXPRO subst seche 10 pce
- Description (DE)
- M M RVAXPRO Trockensub 10 Stk
- Market launch
- 13/02/2007
- Narcotic (BTM)
- No
Application methods
SUBC